121 related articles for article (PubMed ID: 8035607)
1. Ectopic expression of myc or myn down-regulates immunoglobulin transcription.
Sigvardsson M; Johansson K; Larsson LG; Nilsson K; Leanderson T
Leukemia; 1994 Jul; 8(7):1157-63. PubMed ID: 8035607
[TBL] [Abstract][Full Text] [Related]
2. Activator proteins which regulate immunoglobulin heavy chain gene transcription in B lymphocytes.
Roman C; Riggs K; Merrell K; Calame K
Prog Clin Biol Res; 1990; 352():241-8. PubMed ID: 2119507
[TBL] [Abstract][Full Text] [Related]
3. c-Myc does not require max for transcriptional activity in PC-12 cells.
Ribon V; Leff T; Saltiel AR
Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
[TBL] [Abstract][Full Text] [Related]
4. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
6. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
7. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
Berberich SJ; Postel EH
Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
[TBL] [Abstract][Full Text] [Related]
8. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells.
Dunn BK; Cogliati T; Cultraro CM; Bar-Ner M; Segal S
Cell Growth Differ; 1994 Aug; 5(8):847-54. PubMed ID: 7986749
[TBL] [Abstract][Full Text] [Related]
9. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.
Bouchard C; Dittrich O; Kiermaier A; Dohmann K; Menkel A; Eilers M; Lüscher B
Genes Dev; 2001 Aug; 15(16):2042-7. PubMed ID: 11511535
[TBL] [Abstract][Full Text] [Related]
11. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
12. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
[TBL] [Abstract][Full Text] [Related]
13. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
14. Role of c-myc and CD45 in spontaneous and anti-receptor-induced apoptosis in adult murine B cells.
Scott DW; Lamers M; Köhler G; Sidman CL; Maddox B; Carsetti R
Int Immunol; 1996 Sep; 8(9):1375-85. PubMed ID: 8921415
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
Amati B; Dalton S; Brooks MW; Littlewood TD; Evan GI; Land H
Nature; 1992 Oct; 359(6394):423-6. PubMed ID: 1406955
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
[TBL] [Abstract][Full Text] [Related]
17. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
Hu HM; Kanda K; Zhang L; Boxer LM
Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
[TBL] [Abstract][Full Text] [Related]
18. Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
[TBL] [Abstract][Full Text] [Related]
19. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
20. The c-myc protein represses the lambda 5 and TdT initiators.
Mai S; Mårtensson IL
Nucleic Acids Res; 1995 Jan; 23(1):1-9. PubMed ID: 7870572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
